跳至主要内容
临床试验/EUCTR2007-003766-17-NL
EUCTR2007-003766-17-NL进行中(未招募)1 期

Avastin-Injections in Age Related Macular Degeneration:Prospective Study for Optimal Frequency and Follow-up Determination

The Eye Hospital Rotterdam0 个研究点目标入组 311 人开始时间: 2007年7月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
311

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Informed consent
  • - Endophthalmitis risks have been made clear
  • - No preference to paritcipate in the Infliximab for ARMD trial
  • - Age = 65 years
  • - Exudative subfoveolar age related macular degeneration
  • - No significant other ocular disorders affecting visual acuity
  • - Not immunocompromised
  • - No allergy for fluorescein or ICG dye injections
  • - No treatment for ARMD or other retinal problem in the 3 months prior to trial start
  • - No planned ocular surgery in the first year after trial start
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
The Eye Hospital Rotterdam

相似试验